Longevity Health Inc. (XAGE)
NASDAQ: XAGE
· Real-Time Price · USD
2.71
-0.02 (-0.73%)
At close: Aug 28, 2025, 11:42 AM
Longevity Health Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Net Income | -1.89M | -1.51M | -814.28K | -1.63M | -3.3M | -3.55M | 3.16M | -11.46M | 317.51K | 576.07K | -3.12M | -5.06M | -346.99K | -527.53K | -234.5K | -87.3K |
Depreciation & Amortization | 65.6K | 73.71K | 38.54K | -270.76K | 58.27K | 57.57K | -349.38K | 423.8K | 62.09K | 59.91K | 59.59K | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 194.32K | 114.83K | 266.18K | 185.7K | 163.7K | 211.47K | 62.38K | 237.76K | 187.03K | 180.51K | 160.07K | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 571.68K | 246.24K | -9.18K | -1.06M | 116.46K | 1.42M | -2.58M | 2.79M | 1.54M | 927.79K | 494.13K | 383.96K | 242.64K | 383.47K | 298.97K | -283.92K |
Other Non-Cash Items | 29.63K | n/a | n/a | 1.24M | 2.13M | 918.03K | -25.06K | 6.01M | -1.87M | -1.68M | -942.09K | 3.28M | -205.3K | -7.61K | -135.4K | -2.65K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -324.31K | n/a | n/a | n/a | 942.09K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 760.69K | 564.38K | -262.5K | -927.79K | -185.47K | 1.29M | -5.67M | -228.76K | 1.54M | 927.79K | 596.39K | 849.6K | 509.05K | 383.47K | 298.97K | -283.92K |
Operating Cash Flow | -836.19K | -752.95K | -772.06K | -1.4M | -1.14M | -1.08M | -3.14M | -5.03M | -5.89K | -171.53K | -2.3M | -934.63K | -43.24K | -151.67K | -70.93K | -373.88K |
Capital Expenditures | n/a | n/a | n/a | n/a | -4 | n/a | n/a | -30.47K | n/a | n/a | -3.58K | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | -150K | n/a | 748.8K | n/a | -748.8K | n/a | 663K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -154.44M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -15K | n/a | n/a | -748.8K | 4.00 | n/a | -663K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -15K | -150K | n/a | n/a | n/a | -748.8K | -663K | 632.53K | -30.47K | n/a | -3.58K | n/a | n/a | n/a | n/a | -154.44M |
Debt Repayment | -127.52K | -121.75K | -121.81K | 341.68K | -211.1K | -227.26K | -445.2K | -3.09M | 473.5K | 375K | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -86.31K | n/a | -31.54K | 31.54K | -803.42K | 15.46M | 25.88K | n/a | 1.58M | 1.16M | -27.79K | -27.79K | -4.53K | -56.23K |
Financial Cash Flow | 1.63M | 1.52M | -208.12K | 341.68K | 2.44M | -195.73K | -1.25M | 12.41M | -375K | 375K | 2.42M | 1.16M | -27.79K | -27.79K | -4.53K | 155.66M |
Net Cash Flow | 781.15K | 612.91K | -980.19K | -1.06M | 1.31M | -2.02M | -5.06M | 7.96M | -5.89K | -171.53K | 117.27K | -540.62K | -43.24K | -179.46K | -75.45K | 849.65K |
Free Cash Flow | -836.19K | -752.95K | -772.06K | -1.4M | -1.14M | -1.08M | -3.14M | -5.06M | -5.89K | -171.53K | -2.3M | -934.63K | -43.24K | -151.67K | -70.93K | -373.88K |